TERF1 (Gene)

Synonyms:ENTREZ:7013, HGNC:11728, MIM:600951, NM_003218, NM_017489, NP_003209, NP_059523, PIN2, TERF1, TRBF1, TRF, TRF1, XM_005251291, XM_005251292, XM_011517582, XM_017013792, XM_024447246, XM_024447247, XP_005251348, XP_005251349, XP_011515884, XP_016869281, XP_024303014, XP_024303015, hTRF1-AS, t-TRF1, telomeric repeat binding factor 1
Omim:OMIM:600951
Id:fd0fa31d-47f8-5a11-ab34-22c72fcc74d9
Hgnc:HGNC:11728
Entrez:7013
Description:telomeric repeat binding factor 1
This gene encodes a telomere specific protein which is a component of the telomere nucleoprotein complex. This protein is present at telomeres throughout the cell cycle and functions as an inhibitor of telomerase, acting in cis to limit the elongation of individual chromosome ends. The protein structure contains a C-terminal Myb motif, a dimerization domain near its N-terminus and an acidic N-terminus. Multiple transcripts of this gene are alternatively spliced products. [provided by RefSeq, Aug 2022]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TERF1's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TERF1.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TERF1.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TERF1.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TERF1.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.